Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato.
Western blots (WBs; immunoblots) are a widely used tool for the serodiagnosis of Lyme borreliosis, but so far, no defined criteria for performance, analysis, and interpretation have been established in Europe. For the current study WBs were produced with strains PKa2 (Borrelia burgdorferi sensu stricto), PKo (Borrelia afzelii), and PBi (Borrelia garinii). To improve resolution we used gels of 17 cm in length. In a first step, 13 immunodominant proteins were identified with monoclonal antibodies. Then, the apparent molecular masses of all visually distinguishable bands were determined densitometrically. Approximately 40 bands of between 14 and 100 kDa were differentiated for each strain. From a study with 330 serum samples (from 189 patients with Lyme borreliosis and 141 controls), all observed bands were documented. To establish criteria for a positive WB result, the discriminating ability of a series of band combinations (interpretation rules) were evaluated separately for each strain (for immunoglobulin G [IgG] WB, > 40 combinations; for IgM WB, > 15 combinations). The following interpretation criteria resulting in specificities of greater than 96% were recommended: for IgG WB, at least one band of p83/100, p58, p56, OspC, p21, and p17a for PKa2; at least two bands of p83/100, p58, p43, p39, p30, OspC, p21, p17, and p14 for PKo; and at least one band of p83/100, p39, OspC, p21, and p17b for PBi; for IgM WB, at least one band of p39, OspC, and p17a or a strong p41 band for PKa2; at least one band of p39, OspC, and p17 or a strong p41 band for PKo; and at least one band of p39 and OspC or a strong p41 band for PBi. The overall sensitivity was the highest for PKo WB, followed by PBi and PKa2 WB, in decreasing order. Standardization of WB assays is necessary for comparison of results from different laboratories.
Hauser
U
U
Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie der Ludwig-Maximilians-Universität München, Munich, Germany.
Lehnert
G
G
Lobentanzer
R
R
Wilske
B
B
D000907:Antibodies, Bacterial / Q000097:blood*; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial / Q000032:analysis / Q000737:chemistry; D000954:Antigens, Surface; D001170:Arthritis, Infectious / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D015153:Blotting, Western / Q000592:standards*; D001898:Borrelia / Q000276:immunology; D015748:Borrelia burgdorferi Group / Q000276:immunology* / Q000302:isolation & purification; D005060:Europe; D006801:Humans; D016056:Immunodominant Epitopes / Q000032:analysis; D008074:Lipoproteins; D008193:Lyme Disease / Q000175:diagnosis* / Q000276:immunology; D008970:Molecular Weight; D012680:Sensitivity and Specificity
D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D016056:Immunodominant Epitopes; D008074:Lipoproteins; C072045:OspA protein; C079616:OspC protein